MERLIN THERAPEUTICS Trademark

Trademark Overview

On Tuesday, July 5, 2022, a trademark application was filed for MERLIN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MERLIN THERAPEUTICS trademark a serial number of 97488797. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, January 30, 2026. This trademark is owned by Merlin Therapeutics, Inc.. The MERLIN THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development for the treatment or cure of the rare genetic disorder Neurofibromatosis Type 2; conducting clinical trials for others for the treatment of Neurofibromatosis Type 2
merlin therapeutics

General Information

Serial Number97488797
Word MarkMERLIN THERAPEUTICS
Filing DateTuesday, July 5, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, January 30, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Indication of Colors claimedThe colors blue and green are claimed as a feature of the mark.
Goods and Servicesresearch and development for the treatment or cure of the rare genetic disorder Neurofibromatosis Type 2; conducting clinical trials for others for the treatment of Neurofibromatosis Type 2
Description of MarkThe mark consists of a stylized blue and green hat with a green star at the top point of the hat. To the right of the hat is the word "MERLIN" in blue stylized font with a green star over the letter "I" and the word "THERAPEUTICS" in green stylized font under the word "MERLIN". The color white represents background and is not part of the mark.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 24, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerlin Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19382
Party NameMerlin Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19382

Trademark Events

Event DateEvent Description
Friday, July 8, 2022NEW APPLICATION ENTERED
Sunday, July 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2023ASSIGNED TO EXAMINER
Thursday, April 27, 2023NON-FINAL ACTION WRITTEN
Thursday, April 27, 2023NON-FINAL ACTION E-MAILED
Thursday, April 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 4, 2023NON-FINAL ACTION WRITTEN
Monday, December 4, 2023NON-FINAL ACTION E-MAILED
Monday, December 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, February 28, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, April 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 27, 2025SOU TEAS EXTENSION RECEIVED
Monday, January 27, 2025SOU EXTENSION 1 FILED
Tuesday, January 28, 2025SOU EXTENSION 1 GRANTED
Tuesday, January 28, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 14, 2025SOU TEAS EXTENSION RECEIVED
Monday, July 14, 2025SOU EXTENSION 2 FILED
Monday, July 14, 2025SOU EXTENSION 2 GRANTED
Tuesday, July 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 30, 2026SOU TEAS EXTENSION RECEIVED
Friday, January 30, 2026SOU EXTENSION 3 FILED
Friday, January 30, 2026SOU EXTENSION 3 GRANTED
Saturday, January 31, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics merlin neurofibromatosis treatment type conducting trials others clinical disorder development cure